Brief: HBM Holdings Says Unit And Cullinan Oncology Enters License And Collaboration Agreement

HBM Holdings

14/02/2023 01:20

Feb 14 (Reuters) - Hbm Holdings Ltd  2142.HK :
    * UNIT  AND CULLINAN ONCOLOGY, INC. HAVE ENTERED INTO A
LICENSE
AND COLLABORATION AGREEMENT
    * UNDER DEAL, HBM US TO RECEIVE A ONE-TIME, NON-CREDITABLE
AND
NON-REFUNDABLE UPFRONT PAYMENT OF US$25 MLN
    * HBM US SHALL GRANT EXCLUSIVE SUB-LICENSABLE LICENSE TO
CULLINAN
TO EXPLOIT PRODUCT COMPRISED OF BISPECIFIC ANTIBODY TARGETING
B7H4X4-1BB IN US
    * UNDER AGREEMENT, HBM US SHALL RECEIVE ABOUT US$600 MILLION
IN
POTENTIAL MILESTONE PAYMENTS

Further company coverage:  2142.HK